I think this makes it clear who should get the credit for...

I think this makes it clear who should get the credit for Avexa's excellent investment of $1.5M in Allied, which is now worth about $7M and rising...before Coridon delivers...


bioMD Limited (ASX:BOD), a company with assets in regenerative tissue engineering technologies today announced the appointment of a new Chairman, a new MD and other changes to its Board. This follows
shareholder approval for the acquisition of Allied Medical Ltd., a company that specialises in the sales,
distribution and commercialisation of medical technologies.

Effective immediately, Mr Christopher Catlow, Mr Graeme Rowley, Mr Lee Rodne and Mr Jet Soedirdja have
been appointed Directors to the board of bioMD. Robert Scott, Chairman of bioMD Limited, has advised the
Board of his decision to resign as a director.

Former Allied Medical Chairman Christopher Catlow has been appointed Chairman of the new merged group.
Mr Catlow was the inaugural CFO of Fortescue Metals Group Ltd and played a central role in its
development, in particular raising capital. He has served on the boards of several listed companies. He is
currently Chairman of Sirius Minerals and Indo Mines.

Graeme Rowley and Jet Soedirdja have been appointed to the Board as non‐executive directors.

Graeme Rowley joins from the Allied Medical board. He played a central role in the development of
Fortescue Metals Group Ltd from its inception in 2003. He recently retired as an Executive Director of
Fortescue but continues to serve as a Non‐Executive of the company.

Jet Soedirdja, a director of biotechnology company Avexa Ltd., brings extensive investment markets
experience to the Board. He has held directorships both in Australia and abroad. He is currently an
investment advisor at Bell Potter Securities.